Reposted
Still incredibly disappointing that Canada can look at the consequences of aid cuts by other countries earlier this year, and then not only put out a budget that slashes $2.7 billion from international assistance, but put that $2.7 billion in a column labelled "savings".
One analytical model shows that, as of November 5th, the dismantling of U.S.A.I.D. has already caused the deaths of 600,000 people, two-thirds of them children. https://newyorkermag.visitlink.me/jUzNSc
The Shutdown of U.S.A.I.D. Has Already Killed Hundreds of Thousands
The short documentary “Rovina’s Choice” tells the story of what goes when aid goes.
newyorkermag.visitlink.me
November 7, 2025 at 6:16 AM
Still incredibly disappointing that Canada can look at the consequences of aid cuts by other countries earlier this year, and then not only put out a budget that slashes $2.7 billion from international assistance, but put that $2.7 billion in a column labelled "savings".
Reposted
TODAY! "Making the State Do the Right Thing: a Decade of Jordan's Principle Litigation" w/ David Taylor
🕛 Time: 12:10 - 1:20 PM
📷 In-Person: Weldon Law Building, Room 104 dal.ca/faculty/law/
@schulichlaw.bsky.social
🕛 Time: 12:10 - 1:20 PM
📷 In-Person: Weldon Law Building, Room 104 dal.ca/faculty/law/
@schulichlaw.bsky.social
November 7, 2025 at 2:17 PM
TODAY! "Making the State Do the Right Thing: a Decade of Jordan's Principle Litigation" w/ David Taylor
🕛 Time: 12:10 - 1:20 PM
📷 In-Person: Weldon Law Building, Room 104 dal.ca/faculty/law/
@schulichlaw.bsky.social
🕛 Time: 12:10 - 1:20 PM
📷 In-Person: Weldon Law Building, Room 104 dal.ca/faculty/law/
@schulichlaw.bsky.social
CUSMA vs the USMCA / A short thread.
As many pundits have pointed out amidst trade tensions + tariffs between Canada and the US, it's important to keep an eye on the prize, i.e. the upcoming negotiations over the trade deal between Canada, the US, and Mexico.
In Canada, we call it 'CUSMA'.
As many pundits have pointed out amidst trade tensions + tariffs between Canada and the US, it's important to keep an eye on the prize, i.e. the upcoming negotiations over the trade deal between Canada, the US, and Mexico.
In Canada, we call it 'CUSMA'.
November 7, 2025 at 2:28 PM
CUSMA vs the USMCA / A short thread.
As many pundits have pointed out amidst trade tensions + tariffs between Canada and the US, it's important to keep an eye on the prize, i.e. the upcoming negotiations over the trade deal between Canada, the US, and Mexico.
In Canada, we call it 'CUSMA'.
As many pundits have pointed out amidst trade tensions + tariffs between Canada and the US, it's important to keep an eye on the prize, i.e. the upcoming negotiations over the trade deal between Canada, the US, and Mexico.
In Canada, we call it 'CUSMA'.
👀 Vive la France (if this passes)!!
What an incredible precedent this would set.
What an incredible precedent this would set.
Important development in France for those following #pharma #transparency.
Socialist MPs have proposed an amendment to the 2026 Social Security Financing Bill that could redefine transparency in how medicines are financed and priced. /1🧵 www.assemblee-nationale.fr/dyn/17/amend...
Socialist MPs have proposed an amendment to the 2026 Social Security Financing Bill that could redefine transparency in how medicines are financed and priced. /1🧵 www.assemblee-nationale.fr/dyn/17/amend...
Projet de loi de financement de la sécurité sociale pour 2026 (no 1907) Amendement n°AS118
www.assemblee-nationale.fr
November 6, 2025 at 5:39 PM
👀 Vive la France (if this passes)!!
What an incredible precedent this would set.
What an incredible precedent this would set.
Buried in an Annex to yesterday's federal budget was a very curious statement about the #PMPRB, Canada's drug pricing regulator.
In order to cut costs by 15% (as almost all federal agencies have been mandated to do), the Board would 'modernise its hearings':
budget.canada.ca/2025/report-...
1/4
In order to cut costs by 15% (as almost all federal agencies have been mandated to do), the Board would 'modernise its hearings':
budget.canada.ca/2025/report-...
1/4
November 6, 2025 at 1:27 PM
Buried in an Annex to yesterday's federal budget was a very curious statement about the #PMPRB, Canada's drug pricing regulator.
In order to cut costs by 15% (as almost all federal agencies have been mandated to do), the Board would 'modernise its hearings':
budget.canada.ca/2025/report-...
1/4
In order to cut costs by 15% (as almost all federal agencies have been mandated to do), the Board would 'modernise its hearings':
budget.canada.ca/2025/report-...
1/4
Reposted
Bad to much worse:
www.statnews.com/2025/11/03/g...
When NYT broke news of Tidmarsh's leave, it seemed maybe he was being retaliated against for criticizing commissioner's vouchers. Now it seems he may have used his FDA role for personal vendettas+possible extortion. The civil complaint is shocking.
www.statnews.com/2025/11/03/g...
When NYT broke news of Tidmarsh's leave, it seemed maybe he was being retaliated against for criticizing commissioner's vouchers. Now it seems he may have used his FDA role for personal vendettas+possible extortion. The civil complaint is shocking.
Lawsuit against top FDA drug regulator is packed with incendiary texts, emails
A lawsuit filed against George Tidmarsh, who resigned from a top FDA post on Sunday, includes a series of incendiary texts and emails
www.statnews.com
November 3, 2025 at 5:47 PM
Bad to much worse:
www.statnews.com/2025/11/03/g...
When NYT broke news of Tidmarsh's leave, it seemed maybe he was being retaliated against for criticizing commissioner's vouchers. Now it seems he may have used his FDA role for personal vendettas+possible extortion. The civil complaint is shocking.
www.statnews.com/2025/11/03/g...
When NYT broke news of Tidmarsh's leave, it seemed maybe he was being retaliated against for criticizing commissioner's vouchers. Now it seems he may have used his FDA role for personal vendettas+possible extortion. The civil complaint is shocking.
100%
Per the book review @thelancet.com "The story he tells begins in the Hard Rock Hotel bar in Davos, Switzerland, in January, 2020, where discussions laid the foundation for COVAX".🌐💉
However one views COVAX, this origin story is a bit too typical of how & where key global health decisions are made...
However one views COVAX, this origin story is a bit too typical of how & where key global health decisions are made...
October 31, 2025 at 8:22 PM
100%
For those attending the #BuildingBridges conference in #Amsterdam, I’m re-upping this recent paper documenting the challenges with conditional approval mechanisms. It’s US-focused but insights relevant abroad.
academic.oup.com/healthaffair...
Cc @elstorreele.bsky.social @fatimahassan.bsky.social
academic.oup.com/healthaffair...
Cc @elstorreele.bsky.social @fatimahassan.bsky.social
Flexibility Over Rigor: Stakeholder Acceptance of the Limitations of Confirmatory Studies Following Accelerated Approval
Despite the importance of postmarketing requirements (PMRs) following accelerated approval and well-recognized shortcomings in their rigor and timeliness,
academic.oup.com
October 29, 2025 at 2:51 PM
For those attending the #BuildingBridges conference in #Amsterdam, I’m re-upping this recent paper documenting the challenges with conditional approval mechanisms. It’s US-focused but insights relevant abroad.
academic.oup.com/healthaffair...
Cc @elstorreele.bsky.social @fatimahassan.bsky.social
academic.oup.com/healthaffair...
Cc @elstorreele.bsky.social @fatimahassan.bsky.social
Reposted
The generic version of Trikafta, cystic fibrosis drug, costs $6,375 for a child and $12,750 for an adult per year, compared with a list price that exceeds $300,000 annually in the U.S.
www.statnews.com/pharmalot/20...
www.statnews.com/pharmalot/20...
Advocacy groups form a buyer's club to obtain generic versions of pricey Vertex cystic fibrosis drug
Advocacy groups form a buyer's club to obtain generic versions of pricey Vertex cystic fibrosis drug.
www.statnews.com
October 25, 2025 at 8:34 PM
The generic version of Trikafta, cystic fibrosis drug, costs $6,375 for a child and $12,750 for an adult per year, compared with a list price that exceeds $300,000 annually in the U.S.
www.statnews.com/pharmalot/20...
www.statnews.com/pharmalot/20...
Mere minutes away! Join us if you’re in the HRM.
TODAY! "Making the Technical Political: The Long Road to the Pandemic Agreement" w/Roojin Habibi
🕛 Time: 12:10 - 1:20 PM
📷 In-Person: Weldon Law Building, Room 104 dal.ca/faculty/law/
@schulichlaw.bsky.social
🕛 Time: 12:10 - 1:20 PM
📷 In-Person: Weldon Law Building, Room 104 dal.ca/faculty/law/
@schulichlaw.bsky.social
October 24, 2025 at 2:44 PM
Mere minutes away! Join us if you’re in the HRM.
Reposted
This is a fantastic, well-supported 3-year post-doc in our Division of Medical Ethics at Penn. Please share (and apply if interested!)
1/ Thrilled to announce that @pennmehp.bsky.social is recruiting for our NHGRI-funded postdoctoral fellowship in the ethical, legal, and social implications (ELSI) of genomics. Please share widely.
Details at medicalethicshealthpolicy.med.upenn.edu/elsipostdoc
Details at medicalethicshealthpolicy.med.upenn.edu/elsipostdoc
Penn Medical Ethics and Health Policy | ELSI Genomics Postdoctoral Training Program
About the Fellowship
The mission of the 3-year Penn Postdoctoral Training Program in the Ethical, Legal and Social Implications (ELSI) of Genetics and Genomics, supported by a training grant from...
medicalethicshealthpolicy.med.upenn.edu
October 23, 2025 at 9:45 AM
This is a fantastic, well-supported 3-year post-doc in our Division of Medical Ethics at Penn. Please share (and apply if interested!)
Thrilled to welcome @roojinhabibi.org to @schulichlaw.bsky.social tomorrow!
TOMORROW! "Making the Technical Political: The Long Road to the Pandemic Agreement" w/Roojin Habibi
🕛 Time: 12:10 - 1:20 PM
📷 In-Person: Weldon Law Building, Room 104 dal.ca/faculty/law/
@schulichlaw.bsky.social
🕛 Time: 12:10 - 1:20 PM
📷 In-Person: Weldon Law Building, Room 104 dal.ca/faculty/law/
@schulichlaw.bsky.social
October 23, 2025 at 2:15 PM
Thrilled to welcome @roojinhabibi.org to @schulichlaw.bsky.social tomorrow!
Great thread, summarizing our work on J&J's Advac and the perils of what we term 'platform thinking'!
New paper!
Karim Sariahmed, Janice E. Graham, Matthew Herder & Christopher J. Morten, Public Sector Innovation and the Constraints of “Platform Thinking”: An Account of Johnson & Johnson’s Viral Vector Vaccines, 387 Social Science & Medicine 118687 (2025).
www.sciencedirect.com/science/arti...
1/
Karim Sariahmed, Janice E. Graham, Matthew Herder & Christopher J. Morten, Public Sector Innovation and the Constraints of “Platform Thinking”: An Account of Johnson & Johnson’s Viral Vector Vaccines, 387 Social Science & Medicine 118687 (2025).
www.sciencedirect.com/science/arti...
1/
Public sector innovation and the constraints of ‘platform thinking’: An account of Johnson & Johnson's adenoviral vector vaccines
Scholarship on political economy of vaccines in the COVID-19 era has focused on mRNA. Yet Johnson & Johnson's (J&J) vaccine based on recombinant adeno…
www.sciencedirect.com
October 22, 2025 at 2:32 PM
Great thread, summarizing our work on J&J's Advac and the perils of what we term 'platform thinking'!
What he said.
And I hope that #HESA will hear *evidence* on how attempts to throw $$ at #bigpharma or make industry friendly policies have failed to attract a larger industry presence.
Time for some fresh thinking about how to create/sustain a reliable/affordable supply of essential medicines!
And I hope that #HESA will hear *evidence* on how attempts to throw $$ at #bigpharma or make industry friendly policies have failed to attract a larger industry presence.
Time for some fresh thinking about how to create/sustain a reliable/affordable supply of essential medicines!
Interested to see where Parliament's Standing Committee on Health ( #HESA) goes with this study on "Canada's Pharmaceutical Sovereignty". 🛃💊
October 20, 2025 at 4:20 PM
What he said.
And I hope that #HESA will hear *evidence* on how attempts to throw $$ at #bigpharma or make industry friendly policies have failed to attract a larger industry presence.
Time for some fresh thinking about how to create/sustain a reliable/affordable supply of essential medicines!
And I hope that #HESA will hear *evidence* on how attempts to throw $$ at #bigpharma or make industry friendly policies have failed to attract a larger industry presence.
Time for some fresh thinking about how to create/sustain a reliable/affordable supply of essential medicines!
Just published in Social Science & Medicine! Led by @sariahmed.bsky.social + @cmorten.bsky.social we interrogate how 'platform thinking' constrains not only pharma companies like J&J but also science more broadly.
www.sciencedirect.com/science/arti...
www.sciencedirect.com/science/arti...
Public Sector Innovation and the Constraints of ‘Platform Thinking’: An Account of Johnson & Johnson’s Adenoviral Vector Vaccines
Scholarship on political economy of vaccines in the COVID-19 era has focused on mRNA. Yet Johnson & Johnson’s (J&J) vaccine based on recombinant adeno…
www.sciencedirect.com
October 20, 2025 at 2:10 PM
Just published in Social Science & Medicine! Led by @sariahmed.bsky.social + @cmorten.bsky.social we interrogate how 'platform thinking' constrains not only pharma companies like J&J but also science more broadly.
www.sciencedirect.com/science/arti...
www.sciencedirect.com/science/arti...
TODAY! "Not Lawless at all: Abortion in Canada" w/Martha Paynter
🕛 Time: 12:10 - 1:20 PM
📷 In-Person: Weldon Law Building, Room 104 dal.ca/faculty/law/
@schulichlaw.bsky.social
🕛 Time: 12:10 - 1:20 PM
📷 In-Person: Weldon Law Building, Room 104 dal.ca/faculty/law/
@schulichlaw.bsky.social
October 17, 2025 at 1:22 PM
Reposted
TOMORROW! "Not Lawless at all: Abortion in Canada" w/Martha Paynter
🕛 Time: 12:10 - 1:20 PM
📷 In-Person: Weldon Law Building, Room 104 dal.ca/faculty/law/
@schulichlaw.bsky.social
🕛 Time: 12:10 - 1:20 PM
📷 In-Person: Weldon Law Building, Room 104 dal.ca/faculty/law/
@schulichlaw.bsky.social
October 16, 2025 at 12:49 PM
TOMORROW! "Not Lawless at all: Abortion in Canada" w/Martha Paynter
🕛 Time: 12:10 - 1:20 PM
📷 In-Person: Weldon Law Building, Room 104 dal.ca/faculty/law/
@schulichlaw.bsky.social
🕛 Time: 12:10 - 1:20 PM
📷 In-Person: Weldon Law Building, Room 104 dal.ca/faculty/law/
@schulichlaw.bsky.social
I'm hiring a Legal Research Fellow!
dal.peopleadmin.ca/postings/19632
CC @roojinhabibi.org @drximebena.bsky.social @elstorreele.bsky.social @cmorten.bsky.social @gregggonsalves.bsky.social @reshmagar.bsky.social @hollylynchez.bsky.social @akapczynski.bsky.social @fatimahassan.bsky.social
dal.peopleadmin.ca/postings/19632
CC @roojinhabibi.org @drximebena.bsky.social @elstorreele.bsky.social @cmorten.bsky.social @gregggonsalves.bsky.social @reshmagar.bsky.social @hollylynchez.bsky.social @akapczynski.bsky.social @fatimahassan.bsky.social
Research Fellow
Working in close collaboration with the Chair in Applied Public Health, the Infectious Disease Innovation Governance (IDIG) Research Fellow will play a leading role in a variety of research and capaci...
dal.peopleadmin.ca
October 15, 2025 at 2:04 PM
Reposted
Our FIRST seminar of this academic year - THIS FRIDAY! "Not Lawless at all: Abortion in Canada" w/Martha Paynter
🕛 Time: 12:10 - 1:20 PM
📷 In-Person: Weldon Law Building, Room 104 dal.ca/faculty/law/
@schulichlaw.bsky.social
🕛 Time: 12:10 - 1:20 PM
📷 In-Person: Weldon Law Building, Room 104 dal.ca/faculty/law/
@schulichlaw.bsky.social
October 14, 2025 at 11:59 AM
Our FIRST seminar of this academic year - THIS FRIDAY! "Not Lawless at all: Abortion in Canada" w/Martha Paynter
🕛 Time: 12:10 - 1:20 PM
📷 In-Person: Weldon Law Building, Room 104 dal.ca/faculty/law/
@schulichlaw.bsky.social
🕛 Time: 12:10 - 1:20 PM
📷 In-Person: Weldon Law Building, Room 104 dal.ca/faculty/law/
@schulichlaw.bsky.social
Pssst....I'm hiring a Research Fellow to work on 'infectious disease innovation governance'. If you have legal training and you're interested in issues of access to medicines & global health, please consider applying.
Details at the link below (Nov. 3 deadline):
dal.peopleadmin.ca/postings/19632
Details at the link below (Nov. 3 deadline):
dal.peopleadmin.ca/postings/19632
Research Fellow
Working in close collaboration with the Chair in Applied Public Health, the Infectious Disease Innovation Governance (IDIG) Research Fellow will play a leading role in a variety of research and capaci...
dal.peopleadmin.ca
October 13, 2025 at 3:42 PM
Pssst....I'm hiring a Research Fellow to work on 'infectious disease innovation governance'. If you have legal training and you're interested in issues of access to medicines & global health, please consider applying.
Details at the link below (Nov. 3 deadline):
dal.peopleadmin.ca/postings/19632
Details at the link below (Nov. 3 deadline):
dal.peopleadmin.ca/postings/19632
Reposted
Ottawa abusing access to information law to avoid releasing documents, watchdog says. The Information Commissioner is calling on the government to stop relying on legal exemptions she says are overused.
www.theglobeandmail.com/politics/art... via @theglobeandmail.com #FOI #SecretCanada
www.theglobeandmail.com/politics/art... via @theglobeandmail.com #FOI #SecretCanada
Ottawa abusing access to information law to avoid releasing documents, watchdog says
The Information Commissioner is calling on the government to stop relying on legal exemptions she says are overused
www.theglobeandmail.com
September 28, 2025 at 11:50 PM
Ottawa abusing access to information law to avoid releasing documents, watchdog says. The Information Commissioner is calling on the government to stop relying on legal exemptions she says are overused.
www.theglobeandmail.com/politics/art... via @theglobeandmail.com #FOI #SecretCanada
www.theglobeandmail.com/politics/art... via @theglobeandmail.com #FOI #SecretCanada
Reposted
🚨@WorldBank's mission is to fight poverty, yet @IFC_org is funding high-end unaffordable hospitals & exacerbating inequality? This approach will not deliver on the WBs target to reach 1.5 billion with access to quality healthcare! #UHC #PeopleOverProfits www.bloomberg.com/news/article...
Rights Groups Call for Probe of World Bank Hospital Funding
More than 50 human rights organizations, nonprofits and international development experts are calling on the World Bank to investigate its health-care investments in Africa and Asia, citing Bloomberg ...
www.bloomberg.com
September 23, 2025 at 8:06 AM
🚨@WorldBank's mission is to fight poverty, yet @IFC_org is funding high-end unaffordable hospitals & exacerbating inequality? This approach will not deliver on the WBs target to reach 1.5 billion with access to quality healthcare! #UHC #PeopleOverProfits www.bloomberg.com/news/article...
Live in the Halifax area but concerned about global health?
This talk on Thursday featuring @stephanienolen.bsky.social is NOT to be missed!
This talk on Thursday featuring @stephanienolen.bsky.social is NOT to be missed!
September 22, 2025 at 4:04 PM
Live in the Halifax area but concerned about global health?
This talk on Thursday featuring @stephanienolen.bsky.social is NOT to be missed!
This talk on Thursday featuring @stephanienolen.bsky.social is NOT to be missed!
New paper alert! Led by @hollylynchez.bsky.social we report findings from interviews with reps from @fda.gov, pharma, patient orgs + payers about the challenges involved in securing rigorous safety/efficacy evidence re: drugs granted accelerated approval.
See the thread below for details.
See the thread below for details.
Here's our new article reporting findings from stakeholder interviews in which we hoped to learn what it takes to successfully complete rigorous confirmatory studies after accelerated approval. Instead, we mostly heard willingness to trade rigor for feasibility. 1/
academic.oup.com/healthaffair...
academic.oup.com/healthaffair...
Flexibility Over Rigor: Stakeholder Acceptance of the Limitations of Confirmatory Studies Following Accelerated Approval
Despite the importance of postmarketing requirements (PMRs) following accelerated approval and well-recognized shortcomings in their rigor and timeliness,
academic.oup.com
September 22, 2025 at 10:56 AM
New paper alert! Led by @hollylynchez.bsky.social we report findings from interviews with reps from @fda.gov, pharma, patient orgs + payers about the challenges involved in securing rigorous safety/efficacy evidence re: drugs granted accelerated approval.
See the thread below for details.
See the thread below for details.